Screener
First Tracks Biotherapeutics Inc TRAX Investing Cash Flow
Investing Cash Flow at other companies
Where this comes from
Reported directly by First Tracks Biotherapeutics Inc in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The source filing: First Tracks Biotherapeutics Inc’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 4:32 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-224190
| (in thousands) | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Purchase of investments | — | (122,547) |
| Sales and maturities of investments | 35,000 | 137,429 |
| Purchases of property and equipment | (17) | (35) |
| Net cash provided by investing activities | 34,983 | 14,847 |
| CASH FLOWS FROM FINANCING ACTIVITIES: | ||
| Net parent investment | 7,851 | 5,716 |
| Net cash provided by financing activities | 7,851 | 5,716 |
| Net increase (decrease) in cash and cash equivalents | 10,273 | (24,443) |
Item 1. Combined Financial Statements.
FAQ
- What is First Tracks Biotherapeutics Inc's investing cash flow?
- First Tracks Biotherapeutics Inc (TRAX) reported investing cash flow of $34.98M in Q1 2026.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.
Ask your AI about First Tracks Biotherapeutics Inc's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude